Impact of oral anti–hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

INTRODUCTION: Most hepatocellular carcinomas (HCC) develop in a background of underlying liver disease including chronic hepatitis B. However, the effect of antiviral therapy on the long-term outcome of patients with hepatitis B virus (HBV)-related HCC treated with chemoembolization is unclear. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhong-Guo, Zheng, Xing-Rong, Zhou, Qian, Shi, Ming, Zhang, Yao-Jun, Guo, Rong-Ping, Yuan, Yun-Fei, Chen, Min-Shan, Lin, Xiao-Jun, Lao, Xiang-Ming, Li, Sheng-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593372/
https://www.ncbi.nlm.nih.gov/pubmed/26058595
http://dx.doi.org/10.1186/s40880-015-0017-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593372/
https://www.ncbi.nlm.nih.gov/pubmed/26058595
http://dx.doi.org/10.1186/s40880-015-0017-7

Ejemplares similares